Patents by Inventor Hisayuki Nomiyama

Hisayuki Nomiyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8980272
    Abstract: The present invention relates to a method of detecting metabolic bone disorders using a gene expressed at a high level in osteoclasts, a method of screening for a compound effective for treatment and/or prevention of metabolic bone disorders, and a pharmaceutical composition for treatment and/or prevention of metabolic bone disorders. Specifically, the present invention relates to a method of detecting metabolic bone disorders using expression of the human DC-STAMP gene as an indicator, a pharmaceutical composition containing an antibody which is capable of specifically recognizing human DC-STAMP and suppressing formation of osteoclasts, and so forth.
    Type: Grant
    Filed: August 11, 2006
    Date of Patent: March 17, 2015
    Assignee: Sankyo Company, Limited
    Inventors: Hisayuki Nomiyama, Toshio Kukita, Yoshiharu Hiruma
  • Publication number: 20070081974
    Abstract: The present invention relates to a method of detecting metabolic bone disorders using a gene expressed at a high level in osteoclasts, a method of screening for a compound effective for treatment and/or prevention of metabolic bone disorders, and a pharmaceutical composition for treatment and/or prevention of metabolic bone disorders. Specifically, the present invention relates to a method of detecting metabolic bone disorders using expression of the human DC-STAMP gene as an indicator, a pharmaceutical composition containing an antibody which is capable of specifically recognizing human DC-STAMP and suppressing formation of osteoclasts, and so forth.
    Type: Application
    Filed: August 11, 2006
    Publication date: April 12, 2007
    Inventors: Hisayuki Nomiyama, Toshio Kukita, Yoshiharu Hiruma
  • Publication number: 20070031421
    Abstract: The present invention relates to a method of detecting metabolic bone disorders using a gene expressed at a high level in osteoclasts, a method of screening for a compound effective for treatment and/or prevention of metabolic bone disorders, and a pharmaceutical composition for treatment and/or prevention of metabolic bone disorders. Specifically, the present invention relates to a method of detecting metabolic bone disorders using expression of the human DC-STAMP gene as an indicator, a pharmaceutical composition containing an antibody which is capable of specifically recognizing human DC-STAMP and suppressing formation of osteoclasts, and so forth.
    Type: Application
    Filed: August 11, 2006
    Publication date: February 8, 2007
    Inventors: Hisayuki Nomiyama, Toshio Kukita, Yoshiharu Hiruma